Navigation Links
Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

NEW YORK, April 28, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

A patient specific case scenario on advanced lung cancer in a situation involving a patient with EGFR Mutation Positive Adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals:

• Decisions in treatment and tests through disease stages

• Factors influencing their decisions

• Barriers to optimal patient care

• Confidence in treatment

Data has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Advanced Lung Cancer.

Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.

This report allows you to:

• Understand what occurs with actual patients

• Access the most up-to-date prescribing trends

• Gain actionable data for developing and improving your market strategies

• Pinpoint needs of your target audience

• Focus resources to maximize the effectiveness of your budget

• Understand where your product fits

• Understand where your competitor's product fits

• Design messages to advance brand performance

Table of Contents

Executive Summary - US Oncologist Survey5

Optimizing Treatment of Advanced Lung Cancer:5

Chapter 1: Introduction6

Table 1: Treatment Options in Advanced Lung Cancer6

Chapter 2: Respondent Demographics8

Table 2: Eligibility Criteria for Survey Participation8

Figure 2.1 Gender of Survey Respondents8

Figure 2.2 Years Since Medical School Graduation9

Figure 2.3 Practice Settings9

Figure 2.4 Practices in NCI Cancer Centers10

Figure 2.5 Geographic Settings10

Figure 2.6 Survey Respondents by State's Lung Cancer Mortality11

Figure 2.7 Number of Physicians in Practice Groups12

Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen12

Chapter 3: Treatment of an EGFR Mutation Positive Adenocarcinoma13

Figure 3.1 First line chemotherapy regimen13

Figure 3.2 Factors influencing treatment decision14

Figure 3.3 Confidence in treating patient to an optimal outcome16

Figure 3.4 Sequence of treatment choices17

Figure 3.5 Factors influencing treatment decision18

Figure 3.6 Barriers to management of advanced lung cancer20

Chapter 4: Summary23

Appendix A: Survey Instrument24

Companies mentioned

Eli Lilly, Genentech/Roche, Bristol-Myers Squibb, Glaxo Smith Kline, Pfizer, Sanofi-aventis

To order this report:

: Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
3. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
4. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
5. Reportlinker Adds Forecast Insight: Antibacterials
6. Reportlinker Adds Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
7. Reportlinker Adds European Smart Homes and Assisted Living Market (2010-2015)
8. Reportlinker Adds The Outlook for Pharmaceuticals in Latin America
9. Reportlinker Adds Global Respiratory Care Devices Market (2010 - 2015)
10. Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011
11. Reportlinker Adds Epidemiology: Sepsis
Post Your Comments:
(Date:11/25/2015)... N.C. , Nov. 25, 2015 ... the planned investment of at least $15.8  Million ... Wilmington, NC . The expansion ... capacity to meet the growing demands of the ... site expansion will provide up to ...
(Date:11/25/2015)... , Nov. 25, 2015  Henry Schein, Inc., the ... to office-based dental, medical and animal health practitioners, will ... the Henry Schein ConnectDental® Pavilion , which brings ... of open solutions designed to help any practice or ... here for a schedule of experts appearing at ...
(Date:11/25/2015)... 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), ... Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to ... Annual Piper Jaffray Healthcare Conference. th ... Palace Hotel in New York ... Mr. Schuh will be available for one-on-one meetings during ...
Breaking Medicine Technology:
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed ... 1-1 ). More than 3.7 billion people under the age of 50 – or ... to WHO's first global estimates of HSV-1 infection . , "The data shocks us ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):